293 related articles for article (PubMed ID: 14985228)
1. Model of nonalcoholic steatohepatitis.
Lieber CS; Leo MA; Mak KM; Xu Y; Cao Q; Ren C; Ponomarenko A; DeCarli LM
Am J Clin Nutr; 2004 Mar; 79(3):502-9. PubMed ID: 14985228
[TBL] [Abstract][Full Text] [Related]
2. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
Zou Y; Li J; Lu C; Wang J; Ge J; Huang Y; Zhang L; Wang Y
Life Sci; 2006 Aug; 79(11):1100-7. PubMed ID: 16624332
[TBL] [Abstract][Full Text] [Related]
3. Acarbose attenuates experimental non-alcoholic steatohepatitis.
Lieber CS; Leo MA; Mak KM; Xu Y; Cao Q; Ren C; Ponomarenko A; DeCarli LM
Biochem Biophys Res Commun; 2004 Mar; 315(3):699-703. PubMed ID: 14975757
[TBL] [Abstract][Full Text] [Related]
4. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax.
Wang Y; Ausman LM; Russell RM; Greenberg AS; Wang XD
J Nutr; 2008 Oct; 138(10):1866-71. PubMed ID: 18806094
[TBL] [Abstract][Full Text] [Related]
5. Role of medium-chain triglycerides in the alcohol-mediated cytochrome P450 2E1 induction of mitochondria.
Lieber CS; Cao Q; DeCarli LM; Leo MA; Mak KM; Ponomarenko A; Ren C; Wang X
Alcohol Clin Exp Res; 2007 Oct; 31(10):1660-8. PubMed ID: 17681033
[TBL] [Abstract][Full Text] [Related]
6. Effect of dietary fat to produce non-alcoholic fatty liver in the rat.
Ahmed U; Redgrave TG; Oates PS
J Gastroenterol Hepatol; 2009 Aug; 24(8):1463-71. PubMed ID: 19702912
[TBL] [Abstract][Full Text] [Related]
7. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects versus toxicity of medium-chain triacylglycerols in rats with NASH.
Lieber CS; DeCarli LM; Leo MA; Mak KM; Ponomarenko A; Ren C; Wang X
J Hepatol; 2008 Feb; 48(2):318-26. PubMed ID: 18093684
[TBL] [Abstract][Full Text] [Related]
9. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
[TBL] [Abstract][Full Text] [Related]
10. Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats.
Wang Y; Seitz HK; Wang XD
Alcohol Clin Exp Res; 2010 Mar; 34(3):567-73. PubMed ID: 20028348
[TBL] [Abstract][Full Text] [Related]
11. PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.
Abdelmegeed MA; Yoo SH; Henderson LE; Gonzalez FJ; Woodcroft KJ; Song BJ
J Nutr; 2011 Apr; 141(4):603-10. PubMed ID: 21346097
[TBL] [Abstract][Full Text] [Related]
12. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.
Abdelmegeed MA; Banerjee A; Yoo SH; Jang S; Gonzalez FJ; Song BJ
J Hepatol; 2012 Oct; 57(4):860-6. PubMed ID: 22668639
[TBL] [Abstract][Full Text] [Related]
13. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.
Svegliati-Baroni G; Candelaresi C; Saccomanno S; Ferretti G; Bachetti T; Marzioni M; De Minicis S; Nobili L; Salzano R; Omenetti A; Pacetti D; Sigmund S; Benedetti A; Casini A
Am J Pathol; 2006 Sep; 169(3):846-60. PubMed ID: 16936261
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
[TBL] [Abstract][Full Text] [Related]
15. Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.
Gopal T; Kumar N; Perriotte-Olson C; Casey CA; Donohue TM; Harris EN; Talmon G; Kabanov AV; Saraswathi V
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G428-G438. PubMed ID: 31928222
[TBL] [Abstract][Full Text] [Related]
16. The restorative effect of taurine on experimental nonalcoholic steatohepatitis.
Chen SW; Chen YX; Shi J; Lin Y; Xie WF
Dig Dis Sci; 2006 Dec; 51(12):2225-34. PubMed ID: 17080243
[TBL] [Abstract][Full Text] [Related]
17. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
Kohli R; Kirby M; Xanthakos SA; Softic S; Feldstein AE; Saxena V; Tang PH; Miles L; Miles MV; Balistreri WF; Woods SC; Seeley RJ
Hepatology; 2010 Sep; 52(3):934-44. PubMed ID: 20607689
[TBL] [Abstract][Full Text] [Related]
18. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
Ganz M; Csak T; Szabo G
World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
[TBL] [Abstract][Full Text] [Related]
19. Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis.
Yang HY; Tzeng YH; Chai CY; Hsieh AT; Chen JR; Chang LS; Yang SS
Nutrition; 2011 Sep; 27(9):943-8. PubMed ID: 21333494
[TBL] [Abstract][Full Text] [Related]
20. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
Gao Y; Song LX; Jiang MN; Ge GY; Jia YJ
Inflammation; 2008 Apr; 31(2):121-32. PubMed ID: 18302012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
